Ligand validation:7KEP

NXL: (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide

NXL is a Ligand Of Interest in 7KEP designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7KEP_NXL_A_401	68%	32%	0.142	0.953	1.06	1.73	1	4	0	0	100%	0.87
7MEB_NXL_A_401	78%	27%	0.113	0.957	1.15	1.9	2	7	0	0	100%	0.68
7MEC_NXL_A_401	74%	33%	0.112	0.942	1.21	1.54	2	3	0	0	100%	0.86
7KER_NXL_A_401	72%	42%	0.145	0.971	1.17	1.12	2	2	1	0	100%	0.4729
7LNQ_NXL_A_401	71%	32%	0.123	0.943	1.16	1.65	2	5	0	0	100%	0.83
7MEA_NXL_A_401	66%	30%	0.14	0.946	1.23	1.66	2	4	0	0	100%	0.61
4HBU_NXL_A_301	100%	50%	0.04	0.993	0.54	1.37	-	3	0	0	100%	1
4S2I_NXL_B_301	95%	14%	0.067	0.971	2.1	1.99	4	6	0	0	100%	1
8EK9_NXL_A_301	94%	11%	0.067	0.968	1.93	2.38	4	5	0	0	100%	1
5MOZ_NXL_A_701	94%	22%	0.067	0.967	1.87	1.56	4	5	0	0	100%	0.9412
4S2K_NXL_C_301	94%	18%	0.075	0.974	1.13	2.54	1	7	1	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.